C12Q 1/34
Involving hydrolase
Official title: involving hydrolase
C12Q1/34 (Involving hydrolase) appears on 4,193 US grants and 5,440 published applications in this corpus.
Search patents in C12Q- Granted patents
- 4,193
- Published applications
- 5,440
- Assignees
- 2,395
- Inventors
- 11,888
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 15 | 0 |
| 1977 | 18 | 0 |
| 1978 | 18 | 0 |
| 1979 | 18 | 0 |
| 1980 | 29 | 0 |
| 1981 | 35 | 0 |
| 1982 | 20 | 0 |
| 1983 | 27 | 0 |
| 1984 | 22 | 0 |
| 1985 | 27 | 0 |
| 1986 | 29 | 0 |
| 1987 | 44 | 0 |
| 1988 | 33 | 0 |
| 1989 | 45 | 0 |
| 1990 | 40 | 0 |
| 1991 | 35 | 0 |
| 1992 | 48 | 0 |
| 1993 | 60 | 0 |
| 1994 | 52 | 0 |
| 1995 | 59 | 0 |
| 1996 | 59 | 0 |
| 1997 | 73 | 0 |
| 1998 | 126 | 0 |
| 1999 | 107 | 0 |
| 2000 | 77 | 0 |
| 2001 | 111 | 31 |
| 2002 | 110 | 165 |
| 2003 | 104 | 263 |
| 2004 | 109 | 258 |
| 2005 | 85 | 275 |
| 2006 | 108 | 250 |
| 2007 | 119 | 244 |
| 2008 | 134 | 181 |
| 2009 | 102 | 256 |
| 2010 | 115 | 235 |
| 2011 | 123 | 227 |
| 2012 | 121 | 210 |
| 2013 | 140 | 225 |
| 2014 | 146 | 279 |
| 2015 | 156 | 248 |
| 2016 | 154 | 227 |
| 2017 | 149 | 184 |
| 2018 | 130 | 196 |
| 2019 | 133 | 180 |
| 2020 | 140 | 209 |
| 2021 | 108 | 158 |
| 2022 | 116 | 184 |
| 2023 | 99 | 143 |
| 2024 | 97 | 209 |
| 2025 | 107 | 228 |
| 2026 | 61 | 175 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Integrated method for urinary prostate specific Antigen N-glycosylation profiling by capillary electrophoresis6 Oct 2026US 12,754,163 B2Pannon Egyetem
- Method for analyzing protein29 Sep 2026US 12,747,465 B2Hitachi, Ltd.
- Method for producing an exdotoxin measuring agent29 Sep 2026US 12,748,115 B2Seikagaku Corporation
- Immune enhancers8 Sep 2026US 12,729,394 B2Deutsches Krebsforschungszentrum
- Methods of characterizing and purifying VEGF receptor fusion protein25 Aug 2026US 12,715,905 B2Regeneron Pharmaceuticals, Inc.
- Assay for Rapid Detection of Antibiotic Resistant Organisms8 Oct 2026US 2026/0308658 A1Queen's University at Kingston
- Crispr-cas-based novel guide rna capable of specific detection of norovirus gii.4 and application thereof8 Oct 2026US 2026/0308703 A1Pulmuone Co., Ltd.
- Tau assay8 Oct 2026US 2026/0309720 A1
- Ph20 polypeptide variants, formulations and uses thereof1 Oct 2026US 2026/0297551 A1Halozyme, Inc.
- Increasing the sensitivity of a crispr-cas nucleic acid detection system1 Oct 2026US 2026/0297656 A1Nederlandse Organisatie voor toegepast-natuurwetenschappelijk onderzoek TNO
Most cited
By later US patents
- Methods for identifying nucleic acid ligands856US 5,270,163 AUniversity Research Corporation · 1993
- Nucleic acid ligands561US 5,475,096 AUniversity Research Corporation · 1995
- Method and system for determining bioactive substances458US 5,411,866 ANational Research Council of Canada · 1995
- Device and method for pressure-driven plug transport and reaction451US 7,129,091 B2The University of Chicago · 2006
- Combined assay for current glucose level and intermediate or long-term glycemic control340US 5,695,949 ALXN Corporation · 1997